FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Reuters

Drug developer Generate Biomedicines raises $400 million in US IPO

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
FierceBiotech

Generate plans $425M IPO to bankroll antibody's phase 3 asthma trials

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
The Boston Globe

Flagship-backed Generate Biomedicines seeks $425 million in IPO

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
The Verge

ByteDance’s next-gen AI model can generate clips based on text, images, audio, and video

Seedance 2.0 can take camera movement, visual effects, and motion into account. Seedance 2.0 can take camera movement, visual effects, and motion into account. is a news writer who covers the ...
The Business Journals

Generate:Biomedicines eyes public markets as AI drug advances to late-stage trials

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
CNBC

Your income-generating investments could create a tax bill. How to prepare for the season

The tax-filing season is officially underway, and investors – especially those who are holding income-generating assets – will want to prepare to pay the tax man. The Internal Revenue Service began ...
PBS

Musk's Grok AI faces more scrutiny after generating sexual deepfake images

Elon Musk was forced to put restrictions on X and its AI chatbot, Grok, after its image generator sparked outrage around the world. Grok created non-consensual sexualized images, prompting some ...
Seeking Alpha

Recursion jumps as J.P. Morgan upgrades on lead program

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Benzinga.com

Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
Search Engine Land

Google says don’t use JavaScript to generate a noindex tag in the original page code

Google has updated its JavaScript SEO basics documentation to clarify how Google’s crawler handles noindex tags in pages that use JavaScript. In short, if “you do want the page indexed, don’t use a ...
earth

Scientists build ingenious device that can generate electricity from the cold night sky

On clear nights, Earth quietly leaks heat into space. Engineers at UC Davis have now shown that this natural cooling can create a steady energy flow. Their small outdoor engine used the night sky as a ...